Healthcare provider profile · identity verified

Mark R Brumm, MD

Family Practice · LA CROSSE, WI · NPI 1780674283

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	596	158
Amlodipine Besylate	Amlodipine Besylate	502	153
Omeprazole	Omeprazole	351	82
Simvastatin	Simvastatin	292	75
Lisinopril	Lisinopril	281	79
Metoprolol Succinate	Metoprolol Succinate	267	68
Losartan Potassium	Losartan Potassium	239	66
Metformin Hcl Er	Metformin Hcl	220	51
Tamsulosin Hcl	Tamsulosin Hcl	220	52
Levothyroxine Sodium	Levothyroxine Sodium	195	48
Metformin Hcl	Metformin Hcl	182	42
Hydrochlorothiazide	Hydrochlorothiazide	177	51
Gabapentin	Gabapentin	158	44
Eliquis	Apixaban	154	32
Rosuvastatin Calcium	Rosuvastatin Calcium	144	45
Metoprolol Tartrate	Metoprolol Tartrate	127	32
Pantoprazole Sodium	Pantoprazole Sodium	127	37
Glimepiride	Glimepiride	122	30
Warfarin Sodium	Warfarin Sodium	113	26
Escitalopram Oxalate	Escitalopram Oxalate	108	27
Furosemide	Furosemide	102	31
Albuterol Sulfate Hfa	Albuterol Sulfate	92	26
Jardiance	Empagliflozin	87	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	25
Duloxetine Hcl	Duloxetine Hcl	86	21
Potassium Chloride	Potassium Chloride	83	24
Trazodone Hcl	Trazodone Hcl	82	21
Finasteride	Finasteride	79	19
Alendronate Sodium	Alendronate Sodium	78	20
Trulicity	Dulaglutide	76	13
Glipizide Er	Glipizide	73	14
Fluticasone Propionate	Fluticasone Propionate	69	23
Xarelto	Rivaroxaban	68	15
Carvedilol	Carvedilol	65	18
Pravastatin Sodium	Pravastatin Sodium	61	19
Spironolactone	Spironolactone	60	13
Sertraline Hcl	Sertraline Hcl	57	19
Pregabalin	Pregabalin	54	12
Ezetimibe	Ezetimibe	51	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	16
Clopidogrel	Clopidogrel Bisulfate	49	suppressed
Tramadol Hcl	Tramadol Hcl	47	13
Fluoxetine Hcl	Fluoxetine Hcl	46	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	13
Mounjaro	Tirzepatide	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Atenolol	Atenolol	43	13
Oxycodone Hcl	Oxycodone Hcl	43	17
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Allopurinol	Allopurinol	38	13
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Torsemide	Torsemide	34	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Lovastatin	Lovastatin	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Famotidine	Famotidine	29	suppressed
Lorazepam	Lorazepam	28	15
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Prednisone	Prednisone	27	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Methadone Hcl	Methadone Hcl	26	suppressed
Nitroglycerin	Nitroglycerin	26	14
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Diazepam	Diazepam	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nystatin	Nystatin	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Desmopressin Acetate	Desmopressin Acetate	17	suppressed
Baclofen	Baclofen	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lactulose	Lactulose	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Dapsone	Dapsone	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Linzess	Linaclotide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Glipizide	Glipizide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error